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Abstract: Candida auris is an emerging multidrug resistant infectious yeast which is challenging
to eradicate and despite available laboratory methods is still difficult to identify especially in less
developed countries. To limit the rapid spread of C. auris, quick and accurate detection is essential.
From the perspective of disease surveillance, additional methods of tracking this yeast are needed.
In order to increase global preparedness, we explored the use of online search behavior to monitor
the recent global spread of C. auris. We used Google Trends to assess online search behavior on
C. auris from January 2016 until August 2018. Weekly Google Trends results were counted as hits and
compared to confirmed C. auris cases obtained via publications and a global expert network of key
opinion leaders. A total of 44 countries generated a hit, of which 30% (13/44) were confirmed known
cases, 34% (15/44) were missed known cases, 34% (15/44) were hits for unknown cases, and 2% (1/44)
were confirmed unknown cases. Conclusions: Google Trends searches is rapidly able to provide
information on countries with an increased search interest in C. auris. However, Google Trends search
results do not generally coincide with C. auris cases or clusters. This study did show that using Google
Trends provides both insight into the known and highlights the unknown, providing potential for
surveillance and tracking and hence aid in taking timely precautionary measures.
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1. Introduction
Candida auris is an emerging multidrug resistant infectious yeast which is fast spreading globally
and has reached all inhabited continents [1]. It predominantly spreads in the nosocomial setting.
Since the first report of C. auris in 2009 [2], this yeast has caused increasing numbers of infections
and outbreaks around the globe [3–9]. Candida auris causes bloodstream infections, wound infections,
and otitis [10,11]. It mainly affects vulnerable patient groups such as intensive care patients and
neonates treated in health care facilities [12]. Additionally, due to the predominant nosocomial
spread of C. auris, it is important that health care facilities be aware and ready in case of C. auris
infection (case) or outbreak (cluster) [10,13]. Outbreaks in Europe and the USA could be related
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to introductions of C. auris into the healthcare environments from one or more of the four known
clades [14]. Due to increasing awareness of health care workers, government agencies, and researchers
and better biochemical identification methods due to updates in lab system databases, C. auris becomes
easier to identify [15]. However, this is still not the case in less developed countries. Additionally,
the multidrug resistant nature of C. auris together with its high virulence [12], its capability to survive
from weeks to months in the environment of hospital surfaces, and difficulty in decolonization [7,16]
are reasons for grave concern and raised global awareness and alarm [9,17–19]. This is so especially as
we are still looking for the best way to track the spread of C. auris not just globally but also locally
within institutions [20–23]. Therefore, there is a pressing need for accurate, timely, and efficient ways
of tracking C. auris.
Since the Internet is widely used, it is an interesting source of information which is often used
for academic research such as analysing (micro) blog content or global online search behavior [24].
In particular, the Internet has shown to be a valuable source to detect and monitor disease outbreaks
such as the flu and others [25,26]. Online search behavior has also successfully been used to predict
other infectious diseases including Methicillin-resistant Staphylococcus aureus (MRSA) outbreaks based
on search entries [27]. Since C. auris cases are often location specific, online search behavior data
could be a valuable source of information about emerging C. auris cases and clusters. We explored
the use of online search behavior to monitor the recent global spread of C. auris in order to increase
global preparedness.
2. Materials and Methods
2.1. Design and Setting
An exploratory global study was conducted in which online search behavior on Candida auris was
compared to confirmed C. auris cases or clusters. The latter were derived from scientific peer reviewed
publications of C. auris cases and clusters, searches in grey literature, and internationally conducted
mini surveys within an expert network of key opinion leaders (KOLs) asking about knowledge of
national C. auris cases or occurrence of clusters.
Online search behavior assessment on C. auris was performed between 1 January 2016 and 31
July 2018. Key opinion leaders were asked during 2017 and the first half of 2018 to use their network
to provide unpublished information on cases or clusters in their country of residence. The KOLs in
mycology and/or infection control were selected from those countries that showed activity in their
online search behavior for C. auris but had no published occurrence of cases or clusters in the literature
within the set search interval.
2.2. Identifying C. auris Cases and Clusters
A search for C. auris was conducted in the scientific databases PubMed and Web of Science for the
years 2016 to 2018. Additionally, references in the literature were checked and, when relevant, added to
the literature list. Grey literature was selected based on it being mentioned in the reference list of
selected scientific publications. Websites of interest for grey literature were public health websites
and conference websites in the field of microbiology and mycology. Literature had to be in English.
Literature on scientific evaluations, such as antifungal resistance analyses or typing, and reports based
only on previously obtained isolates without cases or clusters of C. auris detected between 2016 and
the middle of 2018 were excluded.
Key opinion leaders in the field were identified and consulted via expert contacts in the Dutch
field of Infection Control and Mycology. The latter sent messages to KOLs in 12 of 16 countries without
publications but with Google Trends activity or a hit, (Table 1) asking about their knowledge on C. auris
cases or clusters in their country and the month and year of the occurrence between 2016 and the
middle of 2018. Additionally, the experts gathered information from KOLs at the 20th Congress of
the International Society of Human and Animal Mycology (ISHAM 30 June until 4 July 2018 in The
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Netherlands). Replies of the KOLs provided data used for this study including any unpublished
studies or data on C. auris. A report on C. auris was included if a KOL reported a cluster, infection,
or potential index case within the country in the given timeframe.
Table 1. Overview of C. auris in published literature, Google Trends and key opinion leaders (KOL)
from 2016 to the middle of 2018.
Lit+ GT+
(n = 13)
Lit+ GT-
(n = 15)
GT+ Lit-
(n = 16)
Austria Bangladesh Australia
Belgium China Belarus *
Canada France Brazil
Colombia Israel Bulgaria
Germany Japan Chile *
India Kuwait Croatia
Panama Malaysia Finland
Spain Norway Ireland
Switzerland Oman Italy
UK Pakistan Mexico
United Arab Emirates Russia The Netherlands
USA Saudi Arabia Peru *
Venezuela Singapore Philippines *
South Africa Poland
South Korea Sweden
Thailand
Light grey shading is KOL positive (n = 1), dark grey shading is KOL negative (n = 15), * No KOL confirmation
was obtained.
2.3. Assessing Online Search Behavior
To assess online search behavior, Google Trends (GT) was used [28]. This tool provides insight
into search behavior of all people using Google based on specific searches performed in Google
Search. It provides the relative frequency of searches for different countries and regions globally in
the specified time interval. We used a similar approach as has been used in studies that successfully
detected influenza and MRSA outbreaks using GT [26,27]. Although different search engines are used
worldwide, our searches were limited to Google Trends since Google covers approximately 82% of all
Internet searches [29].
Regarding the searches, only the term Candida auris was used since this term is indisputable,
clear and comprehensive. No specific settings for GT were applied other than the search region that
was set to worldwide. Google Trends presents search interest of topics on a scale (0% to 100%) per day
instead of an absolute number thus every set search interval will have a maximum and a minimum
even when absolute search numbers are low during this interval (e.g. without any peaks in search
behavior) [27]. Since C. auris is relatively new, with the first case reported in 2009 [2], and outbreaks
have not been reported in every country, search intervals were set to one week, starting on 1 January
2016 when C. auris picked up global interest. In addition, as of January 2016, Google Trends improved
their system on information gathering [28]. The location (country) with the highest (100%) search
interest for the term Candida auris per week was gathered and defined as a hit. The hits were added to
our database.
2.4. Analysis
A Table was created based on the finding of C. auris in the literature/KOL information and the
GT hits, see Table 1. In addition, information from the literature/KOL and GT was combined and
added to a table in alphabetical order (number of cases, country, and period, see Table S1). Countries
with overlap in C. auris data collection and GT hit were added to a separate table if information on
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timeframe including month and year of cases was available. Detection of overlap in timeframe is
interesting as potential for case or cluster identification.
2.5. Ethical Approval
Since the anonymous data used in this study was derived from the public social media domain
without patient involvement and pre-existing contacts of specialists in the field were used, no medical
ethical review was needed in The Netherlands.
3. Results
Between 1 January 2016 and August 2018, we performed searches in GT resulting in hits in
29 countries. Twelve KOLs were consulted, resulting in 1 unknown case in 1 country (Australia).
Table 1 shows the combination of the GT hits with published and unpublished C. auris reports
within the search period. The first column (Lit+ GT+) shows the countries with published reports on
C. auris cases or clusters between 2016 and the middle of 2018 with at least one hit in GT during the
search period (n = 13). More countries had published reports on C. auris but showed no hits in the GT
search (n = 15), which is shown in the second column (Lit+ GT−). The largest group had no published
reports on C. auris cases or clusters but had at least one hit in the GT search (GT+ Lit−) (n = 16). Finally,
the KOL information was used to assess whether countries with GT hits but no present literature were
indeed without cases. Consequently, the final column shows the true positive countries (GT+, Lit−,
KOL+) in light grey (n = 1) and false positive countries for C. auris cases or clusters (GT+, Lit−, KOL−)
in dark grey (n = 15).
The combined literature search and GT hit collection, resulted in a total of 44 countries. Of these,
30% (13/44) were identified known C. auris cases by GT search, 34% (15/44) were missed known C. auris
cases by GT search behavior, 2% (1/44) were confirmed unknown C. auris cases, and 34% (15/44) were
confirmed hits for unknown cases.
Countries with overlap in C. auris data collection presented in the literature and GT hit within the
set search interval were Colombia, the UK and the USA. All three publications provided a date range
for case or cluster collection (see Table 2).
Table 2. A light grey shading of the overlap in the published C. auris cases or clusters and GT hits for
2016 to the middle of 2018.
Country Timeframe (and Number of Cases) GT hits
Colombia February–July 2016 (17) [5]
July 2016, August 2016 (2×), October 2016
(4×), February 2017, July 2017, August 2017,
December 2017, March 2018, April 2018,
May 2018 (2×)
UK a 2 February 2015–31 August 2017 (70) [23]April 2015–July 2016 (50) [7]
January 2016, March 2016 (3×), April 2016,
May 2016, June 2016, August 2016 (2×),
December 2016, February 2017 (2×), August
2017, March 2018, April 2018
USA a May 2013–August 2016 (7) of which 5 inApril–August 2016 [30]
June 2016, July 2016, March 2017, April
2017, March 2018 (2×)
a On 1 July 2016, both the CDC and Public Health England (PHE) issued the first notification for C. auris.
4. Discussion
In this study, we explored the potential value of assessing online search behavior on Candida auris
in relation to C. auris cases or clusters. One third of the hits found in GT were already known C. auris
cases, well described in the literature. It is encouraging that a freely available, easy-to-access tool
such as GT shows these cases. Additionally, our approach rapidly provided us with several new
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insights into C. auris cases, including the finding of one country which indeed had a C. auris case
not known publicly. Interestingly, one third of the GT hits were not confirmed by official data from
publications or KOLs. On the other hand, one third of known C. auris cases were not identified via
online search behavior.
One third (34%) of the hits were not confirmed by literature or KOLs. However, we cannot
conclude that these hits are missed C. auris cases, particularly since not all hits were confirmed by KOL
reply. This finding suggests that one third of the countries had an increased search interest for C. auris
within the 1.5 year set-time interval as these countries peaked in GT. This increased interest could be
on any subject regarding C. auris. However, for a country to come up as a hit in this study, it means
that online search interest within this country was higher than in any other nation, suggesting an
increased interest in C. auris and a potential increase in awareness which is essential for the adequate
identification, treatment, and prevention of this yeast pathogen. This finding highlights the potential
of using online search behavior such as via GT for governments and researchers as a new way of
gathering information, which is strengthened by the knowledge that we live in a digital world in which
we can assume that C. auris is discussed online.
We used Google Trends to identify C. auris cases as has been done for influenza and MRSA
outbreaks previously. However, it is best used for high prevalence, non-emerging but prevalent
diseases, which is not yet the case for C. auris [26]. Candida auris infections are relatively new and
the identification, treatment, and prevention measures are not completely understood and applicable
worldwide [9]. Therefore C. auris might not have the prevalence for proper cluster or case detection
via Google Trends. Especially, since many published C. auris reports consist of <10 cases [6,30–32].
Additionally, the overlap found in published C. auris case collection and GT hit was minimal with
only three countries out of the 28 countries reported to have C. auris cases or clusters (Tables 1 and 2).
Moreover, even for these three countries, the hits in GT currently cannot be linked exclusively to the
published case collection. However, it is to be expected that the ‘critical mass’ for C. auris detection via
Internet will increase as this yeast continues to spread globally, infection cases become more common
and well reported, and the potential for using social media and GT in particular becomes more valuable.
Even though the Internet is indeed worldwide, there is still a difference between more developed
countries and developing countries in its use and accessibility [33]. This might have contributed to the
low (2%, n = 1) number of developed countries (Australia) with an identified unknown case and the
higher number of missed known cases (34%) in countries on the African and Asian continents with
potentially less internet access. However, in our current fast-changing digital era, it is essential that we
explore new ways to track and detect diseases. Using the Internet is one of those methods [24].
Furthermore, as misidentification of C. auris is still a problem in many countries [12], C. auris
might go undetected even when present. Since detection is a predicament in some facilities that are
not using up-to-date equipment or standards [34], possible C. auris isolates might be sent to foreign
laboratories for confirmation. Identification in a facility in another country can possibly result in a
skewed peak search interest in the country of detection rather than the country of C. auris isolate origin.
This might be true, for example, for cases detected in the USA that originated in the Middle East and
infections detected in the UK that had an origin in South Africa [9,23]. This potentially contributes to
the relatively high percentage of missed known cases (34%) and identified hits for unknown cases
(34%) found. Additionally, search activity could have been influenced by publications from national
organisations such as the CDC and PHE. However, this study does show that people are searching for
C. auris and that this yeast is becoming more and more well-known globally.
5. Limitations
The timeframe for the publications to be included was set to either case collection or duration of
the study between 2016 and the middle of 2018 or (first) publication from 2016 to the middle of 2018.
This timeframe was chosen to coincide with the Google Trends search period. It did include some
of the recent major outbreaks, such as known reported outbreaks in the UK and South Africa [7,35].
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However, to create Table 1, the timeframe used did not take into account differences in date of the GT
hit and publication or KOL information date on C. auris within the set timeframe.
Since GT shows the relative frequency of searches for different countries and regions in a specified
time interval, the result differs depending on the time interval chosen. However, since we used search
intervals of a week, we believe this represents true search behavior better than looking at monthly
GT searches.
Finally, we only looked at Candida auris as search term in Google Trends. This can result in a
variety of hits on this topic. In this exploratory study we have specifically looked in the literature and
networks for C. auris cases and clusters, whereas Google searches conducted with the term Candida auris
may have been looking for information on resistance or detection of C. auris and therefore might give a
skewed image for the number of local hits counted as cases or clusters. However, interest in C. auris in
any form might be an indication of infection or potential cases and at least of increased awareness.
6. Conclusions
Google Trends searches rapidly provide information on countries with an increased search interest
in C. auris. Currently, this freely available, easy-to-access tool is encouraging research by trying to
correlate search behavior for C. auris in countries with known infections or cases. However, at the
moment online search behavior for C. auris generates a relatively high misidentification of published
cases and hits for unknown cases and shows little overlap in timeframe for case collection and Google
Trends search behavior. Therefore, it can be concluded that Google Trends searches currently do not
generally coincide with C. auris cases or clusters. More research is needed, especially at a time when
C. auris becomes endemic and thus does not trigger searches by those trying to get informed about an
emerging problem. At that point, Google Trends might be better suited to identify peaks in occurrence,
e.g., outbreaks, as it does for influenza [25]. Particularly in a fast-changing digital world, health care
organisations, professionals, and researchers are prompted to look for new methods of surveillance
and earlier detection of diseases. This study shows that using such a tool both provides insight into
the known and highlights the unknown, providing potential for surveillance and tracking and hence
aid in taking timely precautionary measures.
Supplementary Materials: The following are available online at http://www.mdpi.com/2309-608X/5/2/44/s1,
Table S1: Overview of (un)published C. auris outbreaks or cases, KOL information and GT hits 2016-first half 2018.
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